Dabrafenib is an inhibitor of mutated BRAF kinase and has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma. Molecular Formula: C23H20F3N5O2S2 Solubility: Chloro
Molecular Weight:
519.56
Form:
Supplied as a white to off-white solid.
CAS Number:
[1195765-45-7]
* VAT and and shipping costs not included. Errors and price changes excepted